Taichung, Taiwan

Ju-Fang Liu

This inventor holds 1 USPTO granted patent. Top assignee: China Medical University. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ju-Fang Liu. Retrieved from https://idiyas.com/inventor/ju-fang-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ju-Fang Liu: Innovator in Anticancer Research

Introduction

Ju-Fang Liu is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have potential applications in cancer treatment. His innovative work focuses on the synthesis and application of benzimidazole compounds.

Latest Patents

Ju-Fang Liu holds a patent for "Benzimidazole compounds and their use as anticancer agents." This patent describes benzimidazole compounds of a specific formula, wherein various substituents are defined. The patent also discloses a method for treating cancer using these compounds, showcasing Liu's commitment to advancing cancer therapies. He has 1 patent to his name.

Career Highlights

Liu is affiliated with China Medical University, where he conducts research and collaborates with other scientists. His work has been instrumental in exploring new avenues for cancer treatment, contributing to the ongoing fight against this disease.

Collaborations

Ju-Fang Liu has worked alongside notable colleagues, including Chih-Shiang Chang and Jih-Hwa Guh. Their collaborative efforts have further enhanced the research output and innovation in their respective fields.

Conclusion

Ju-Fang Liu's contributions to the field of anticancer research through his innovative patents and collaborations highlight his role as a key figure in medicinal chemistry. His work continues to inspire advancements in cancer treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…